IL208386A0 - Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents - Google Patents

Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents

Info

Publication number
IL208386A0
IL208386A0 IL208386A IL20838610A IL208386A0 IL 208386 A0 IL208386 A0 IL 208386A0 IL 208386 A IL208386 A IL 208386A IL 20838610 A IL20838610 A IL 20838610A IL 208386 A0 IL208386 A0 IL 208386A0
Authority
IL
Israel
Prior art keywords
microtubule
lipid
oil
delivery system
interacting agents
Prior art date
Application number
IL208386A
Original Assignee
Robert Shorr
Robert Rodriguez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Shorr, Robert Rodriguez filed Critical Robert Shorr
Publication of IL208386A0 publication Critical patent/IL208386A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL208386A 2008-04-04 2010-10-03 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents IL208386A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/004393 WO2009123595A1 (en) 2008-04-04 2008-04-04 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents

Publications (1)

Publication Number Publication Date
IL208386A0 true IL208386A0 (en) 2010-12-30

Family

ID=41135838

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208386A IL208386A0 (en) 2008-04-04 2010-10-03 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents

Country Status (9)

Country Link
EP (1) EP2262369A4 (en)
JP (1) JP2011516472A (en)
KR (1) KR20110009128A (en)
CN (1) CN102046011A (en)
AU (1) AU2008354007A1 (en)
BR (1) BRPI0821895A2 (en)
CA (1) CA2720390A1 (en)
IL (1) IL208386A0 (en)
WO (1) WO2009123595A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110056042A (en) * 2009-11-20 2011-05-26 주식회사유한양행 Nano particles for tumor-targeting and processes for the preparation thereof
BR112012013427B8 (en) 2009-12-03 2021-05-25 Novartis Ag circulation of components during the homogenization of emulsions
DE102009056871A1 (en) * 2009-12-03 2011-06-22 Novartis AG, 4056 Vaccine adjuvants and improved methods of making the same
AU2010325748B2 (en) * 2009-12-03 2014-04-17 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
CL2012001399A1 (en) 2009-12-03 2013-03-08 Novartis Ag Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion.
KR101752944B1 (en) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US9618547B2 (en) 2012-01-24 2017-04-11 University Of Southern California Digital circuit power measurements using numerical analysis
JO3685B1 (en) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc Non-aqueous taxane nanodispersion formulations and methods of using the same
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
US10220095B2 (en) 2013-03-15 2019-03-05 Taiwan Liposome Company, Ltd Controlled drug release liposome compositions and methods thereof
US11172675B2 (en) * 2014-12-22 2021-11-16 Oro Agri Inc. Nano particulate delivery system
US10386395B1 (en) 2015-06-03 2019-08-20 University Of Southern California Subcircuit physical level power monitoring technology for real-time hardware systems and simulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03011593A (en) * 2001-06-15 2005-03-07 Cornestone Pharmaceuticals Nanoparticles for treating targeted tissues and cells.
EP1480636B1 (en) * 2002-03-01 2007-04-18 Novagali Pharma SA Self emulsifying drug delivery systems for taxoids
JP2005538096A (en) * 2002-07-25 2005-12-15 マイジェニックス インコーポレイテッド Antiviral 7-deaza D-nucleosides and methods of use thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20060257493A1 (en) * 2005-04-28 2006-11-16 Amiji Mansoor M Nanoparticulate delivery systems for treating multi-drug resistance
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations

Also Published As

Publication number Publication date
JP2011516472A (en) 2011-05-26
EP2262369A4 (en) 2013-05-29
KR20110009128A (en) 2011-01-27
BRPI0821895A2 (en) 2014-10-07
EP2262369A1 (en) 2010-12-22
CN102046011A (en) 2011-05-04
CA2720390A1 (en) 2009-10-08
WO2009123595A1 (en) 2009-10-08
AU2008354007A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
IL208386A0 (en) Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
ZA201101737B (en) Progestin-containing drug delivery system
EP2341867A4 (en) Reconstrainable stent delivery system
EP2300145A4 (en) Microencapsulated delivery system
GB0903810D0 (en) Delivery system
HK1144375A1 (en) Transdermal delivery system
IL198278A0 (en) Energy-dissipation system
EP2222278A4 (en) Improved taxane delivery system
EP2348209A4 (en) Ammonia-engine system
GB0707928D0 (en) Delivery system
EP2265533A4 (en) Conveyor system
EP2322120A4 (en) Stent delivery system
PL2349881T3 (en) Transport system
PL2174853T3 (en) Seat for chair-lift
GB0909319D0 (en) Transluminal delivery system
IL212357A0 (en) Sustained drug delivery system
EP2416965A4 (en) Ink delivery system
IL210393A0 (en) Administration regime for nitrocatechols
GB0805521D0 (en) Dispensing system
GB0812513D0 (en) Delivery vehicle
EP2360921A4 (en) Content delivering system
EP2331167A4 (en) Anti-needlestick system
GB0817486D0 (en) Delivery system
EP2254649A4 (en) Delivery system attachment
TWI341260B (en) Supply system